Replimune (REPL) Net Cash Flow (2017 - 2026)

Replimune has reported Net Cash Flow for 10 years, with the latest figure at $86.0 million in Q1 2026.

• Quarterly Net Cash Flow rose 239.73% year-over-year to $86.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $96.8 million (up 166.28% YoY) and the FY2026 annual result came in at $96.8 million, up 166.28% from the prior year.
• Net Cash Flow rose to $86.0 million in Q1 2026 per REPL's latest filing, from $19.6 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $117.7 million in Q4 2022 and troughed at -$61.6 million in Q1 2025.
• A 5-year average of $4.4 million and a median of -$12.1 million in 2025 frame the typical range for Net Cash Flow.
• The sharpest annual moves came in 2022 and 2023: Net Cash Flow soared 523.56% in 2022, then plunged 1015.61% in 2023.
• Over 5 years, Net Cash Flow stood at $117.7 million in 2022, then plunged by 81.57% to $21.7 million in 2023, then surged by 171.38% to $58.9 million in 2024, then tumbled by 66.69% to $19.6 million in 2025, then soared by 338.53% to $86.0 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered $86.0 million, $19.6 million, and $3.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.